• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即时检测 C 反应蛋白是否会影响社区呼吸道服务中抗生素的使用?

Does availability of point of care C-reactive protein measurement affect provision of antibiotics in a community respiratory service?

机构信息

Advanced Practitioner; Knowsley Community Respiratory Service, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool.

Consultant Physiotherapist; Knowsley Community Respiratory Service, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool.

出版信息

Br J Community Nurs. 2022 May 2;27(5):218-224. doi: 10.12968/bjcn.2022.27.5.218.

DOI:10.12968/bjcn.2022.27.5.218
PMID:35522449
Abstract

Antibiotic resistance presents a growing threat to health systems and patients at a global scale. Point of care (POC) C-reactive protein (CRP) measurement, as an adjunct to exacerbation assessment, has been studied in primary and secondary care and may represent a useful tool for community teams. A retrospective service review was conducted to determine the effect of CRP measurement on antibiotic provision in a community respiratory setting, with chronic obstructive pulmonary disease (COPD) and bronchiectasis exacerbations. This review compared antibiotic provision for COPD and bronchiectasis patients for those where CRP was measured versus those where it was not. It was found that antibiotic provision dropped by almost 25% points for COPD exacerbations, and almost 59% in bronchiectasis, when a CRP measurement was taken as a component of a respiratory assessment. Antibiotics were also provided at a greater amount based on symptom presentation. Therefore, it is concluded that CRP measurement correlates with a reduction in antibiotic provision, highlighting its use alongside symptom assessment in future work.

摘要

抗生素耐药性在全球范围内对卫生系统和患者构成的威胁日益严重。在初级和二级保健中,已经研究了将即时护理(POC)C 反应蛋白(CRP)测量作为加重评估的辅助手段,它可能是社区团队的一种有用工具。进行了一项回顾性服务审查,以确定 CRP 测量在社区呼吸系统环境中对 COPD 和支气管扩张症加重患者的抗生素提供情况的影响。该审查比较了 CRP 测量的 COPD 和支气管扩张症患者与未进行 CRP 测量的患者的抗生素提供情况。结果发现,当 CRP 测量作为呼吸评估的一部分时,COPD 加重的抗生素提供量下降了近 25%,而支气管扩张症则下降了近 59%。根据症状表现,抗生素的提供量也更大。因此,可以得出结论,CRP 测量与抗生素提供量的减少相关,这突出了在未来工作中与症状评估一起使用 CRP 测量的重要性。

相似文献

1
Does availability of point of care C-reactive protein measurement affect provision of antibiotics in a community respiratory service?即时检测 C 反应蛋白是否会影响社区呼吸道服务中抗生素的使用?
Br J Community Nurs. 2022 May 2;27(5):218-224. doi: 10.12968/bjcn.2022.27.5.218.
2
General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.全科医生使用C反应蛋白即时检验来指导慢性阻塞性肺疾病急性加重患者的抗生素处方(PACE研究):一项随机对照试验的研究方案
Trials. 2017 Sep 29;18(1):442. doi: 10.1186/s13063-017-2144-8.
3
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.C 反应蛋白检测指导 COPD 加重期抗生素的使用。
N Engl J Med. 2019 Jul 11;381(2):111-120. doi: 10.1056/NEJMoa1803185.
4
CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions.基于 CRP 的抗生素治疗用于 COPD 急性加重期住院患者。
Eur Respir J. 2019 May 23;53(5). doi: 10.1183/13993003.02014-2018. Print 2019 May.
5
Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care.基层医疗中哮喘和慢性阻塞性肺疾病急性加重期使用抗生素和全身糖皮质激素治疗的预测因素。
BMC Fam Pract. 2015 Mar 24;16:40. doi: 10.1186/s12875-015-0256-3.
6
C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis.用于指导慢性阻塞性肺疾病急性加重期抗生素处方的C反应蛋白检测:一项系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Jul 17;99(29):e21152. doi: 10.1097/MD.0000000000021152.
7
C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.抗生素治疗慢性阻塞性肺疾病加重和社区获得性肺炎患者后 C 反应蛋白速度。
Eur J Intern Med. 2009 Sep;20(5):518-21. doi: 10.1016/j.ejim.2009.03.008. Epub 2009 Apr 16.
8
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的炎症生物标志物与加重。
JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.
9
The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.老年慢性阻塞性肺疾病和慢性支气管炎急性加重患者的诊断和治疗。
J Am Geriatr Soc. 2010 Mar;58(3):570-9. doi: 10.1111/j.1532-5415.2010.02741.x.
10
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)的预防性抗生素治疗
Cochrane Database Syst Rev. 2013 Nov 28(11):CD009764. doi: 10.1002/14651858.CD009764.pub2.

引用本文的文献

1
Comparative Evaluation of Peripheral Blood Neutrophil to Lymphocyte Ratio, Serum Albumin to Globulin Ratio and Serum C-Reactive Protein to Albumin Ratio in Dogs with Inflammatory Protein-Losing Enteropathy and Healthy Dogs.炎性蛋白丢失性肠病犬与健康犬外周血中性粒细胞与淋巴细胞比值、血清白蛋白与球蛋白比值及血清C反应蛋白与白蛋白比值的比较评估
Animals (Basel). 2023 Jan 30;13(3):484. doi: 10.3390/ani13030484.